Unfortunately, no significant association was found in three independent anti-PD-1 immunotherapy cohorts (Figure 5C), and there was no remarkable relationship between PDCD1 expression and the overall survival or progression-free survival of ccRCC patients treated with ICI (Figure 5A). The gene discussed is PDCD1; the disease is nonpapillary renal cell carcinoma.